Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cuban Sweet Lemon refers to a hydroalcoholic extract from Citrus aurantifolia (lime) leaves, rich in C-glycosyl flavones like vitexin and isovitexin. These compounds demonstrate antiplatelet activity by inhibiting platelet aggregation induced by ADP and epinephrine.
Reported Benefits (Provisional)
Origin & History
Cuban Sweet Lemon (Citrus limon) is a unique, sweet-mild variety of lemon cultivated in the tropical orchards of Cuba. Its warm, sunny climate and fertile soils provide ideal growing conditions. This fragrant citrus is valued in functional nutrition for its high vitamin C content and detoxifying properties.
Research Narrative (Provisional)
Preliminary research indicates interest in Cuban Sweet Lemon's potential for immune health, particularly its antioxidant capacity. Studies are exploring its role in detoxification processes and overall wellness.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamin C: High content, crucial for immune function and collagen production. - Flavonoids: Contribute to antioxidant protection and anti-inflammatory effects. - Potassium: Essential mineral supporting electrolyte balance. - Natural Acids: Aid in detoxification and digestion.
Reported Mechanism (Provisional)
The primary bioactive compounds in Cuban Sweet Lemon extract are C-glycosyl flavones, including vitexin, isovitexin, and novel arabinosyl derivatives, identified via HPLC-PDA-ESI/MS/MS and NMR. These flavonoids exert antiplatelet activity by concentration-dependently inhibiting platelet aggregation induced by agonists like ADP and epinephrine in human plasma. The mechanism is thought to involve the interference of these compounds with platelet agonists, thereby preventing platelet activation and aggregation.
Clinical Narrative (Provisional)
Preliminary *in vitro* studies using human plasma demonstrate that Cuban Sweet Lemon extract (TLL) exhibits concentration-dependent inhibition of platelet aggregation. Specifically, it showed an IC50 of 0.40 mg/mL against ADP-induced aggregation and 0.32 mg/mL against epinephrine-induced aggregation. While promising, these findings are based on *in vitro* models, and further clinical trials are necessary to confirm efficacy and safety in humans.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.